Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom Vink

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Blood|June 21, 2008
Antibody fucosylation differentially impacts cytotoxicity mediated by NK and PMN effector cellsMatthias Peipp, Jeroen J Lammerts van Bueren, Tanja Schneider-Merck, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 4, 2016
Type I CD20 Antibodies Recruit the B Cell Receptor for Complement-Dependent Lysis of Malignant B CellsPatrick J Engelberts, Marleen Voorhorst, Janine Schuurman, et al.
Science (New York, N.Y.)|September 18, 2007
Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchangeMarijn van der Neut Kolfschoten, Janine Schuurman, Mario Losen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 16, 2011
Species-specific determinants in the IgG CH3 domain enable Fab-arm exchange by affecting the noncovalent CH3-CH3 interaction strengthAran F Labrijn, Theo Rispens, Joyce Meesters, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2006
The biological activity of human CD20 monoclonal antibodies is linked to unique epitopes on CD20Jessica L Teeling, Wendy J M Mackus, Luus J J M Wiegman, et al.
Scientific Reports|April 22, 2017
Hinge-deleted IgG4 blocker therapy for acetylcholine receptor myasthenia gravis in rhesus monkeysMario Losen, Aran F Labrijn, Vivianne H van Kranen-Mastenbroek, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 29, 2010
Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumorsMichel de Weers, Yu-Tzu Tai, Michael S van der Veer, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Blood|June 21, 2008
Antibody fucosylation differentially impacts cytotoxicity mediated by NK and PMN effector cellsMatthias Peipp, Jeroen J Lammerts van Bueren, Tanja Schneider-Merck, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 4, 2016
Type I CD20 Antibodies Recruit the B Cell Receptor for Complement-Dependent Lysis of Malignant B CellsPatrick J Engelberts, Marleen Voorhorst, Janine Schuurman, et al.
Science (New York, N.Y.)|September 18, 2007
Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchangeMarijn van der Neut Kolfschoten, Janine Schuurman, Mario Losen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 16, 2011
Species-specific determinants in the IgG CH3 domain enable Fab-arm exchange by affecting the noncovalent CH3-CH3 interaction strengthAran F Labrijn, Theo Rispens, Joyce Meesters, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2006
The biological activity of human CD20 monoclonal antibodies is linked to unique epitopes on CD20Jessica L Teeling, Wendy J M Mackus, Luus J J M Wiegman, et al.
Scientific Reports|April 22, 2017
Hinge-deleted IgG4 blocker therapy for acetylcholine receptor myasthenia gravis in rhesus monkeysMario Losen, Aran F Labrijn, Vivianne H van Kranen-Mastenbroek, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 29, 2010
Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumorsMichel de Weers, Yu-Tzu Tai, Michael S van der Veer, et al.
Pageof 2